The plasma peptides of breast versus ovarian cancer

Table 5 The analysis of mean peptide intensity per gene symbol for QSER1 protein by ANOVA with Tukey–Kramer multiple means comparison

Treatment	Mean	SD	Data N	Tukey–Kramer
1	5.072769	0.302986	21	d
2	4.593409	0.511989	67	cde
3	4.633497	0.3285	26	bde
4	4.056312	0.161037	33	a
5	5.918212	0.760851	25	h
6	5.717592	0.763346	18	h
7	4.837276	0.216573	8	bdef
9	4.542693	0.65645	141	ceg
10	4.600209	0.640097	66	cde
11	4.512103	0.515631	8	acde
12	4.029774	0	4	acde
13	4.452935	0.491664	50	aceg
14	4.12479	0.351469	35	af
15	4.419355	0.198763	53	ace
16	4.324212	0.504538	32	ace
17	4.928881	0.947319	22	dg
18	4.173403	0.478339	36	ab
19	4.740343	0.428142	58	cde
20	4.80151	0.475907	35	de
21	4.749583	0.513686	36	cde
22	4.755553	0.517117	25	cde
23	4.58392	0.466147	11	acde
24	3.736293	0	4	abc
25	4.881761	0.953098	18	de

Treatment ID numbers: 1, Alzheimer normal; 2, Alzheimer’s normal control STYP; 3, Alzheimer’s dementia; 4, Alzheimer’s dementia STYP; 5, Cancer breast; 6, Cancer breast STYP; 7, Cancer control; 8, Cancer control STYP; 9, Cancer ovarian; 10, Cancer ovarian STYP; 11, Ice Cold; 12, Ice Cold STYP; 13, Heart attack Arterial; 14 Heart attack Arterial STYP; 15, Heart attack normal control, 16, Heart attack normal Control STYP; 17, Heart attack; 18, Heart attack STYP; 19, Multiple Sclerosis normal control; 20, Multiple sclerosis normal control STYP; Multiple sclerosis; 22, Multiple Sclerosis STYP, 23 Sepsis; 24, Sepsis STYP; 25, Sepsis normal control; 26, Sepsis normal control STYP. The Tukey–Kramer multiple comparison ranking of mean intensity from R is shown by letters

ISSN: 1559-0275